Kiora Pharmaceuticals developed KIO-104 for ocular diseases, and Brian M. Strem was identified as the company's CEO.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kiora Pharmaceuticals developed KIO-104 for ocular diseases, and Brian M. Strem was identified as the company's CEO.
Coverage
Newest first; wire copies grouped- NewsfileKiora Pharmaceuticals Granted U.S. Patent Expanding Protection for KIO-104 in the Treatment of Ocular Disease Encinitas, California--(Newsfile Corp. - July 22, 2025) - Kiora Pharmaceuticals, Inc. (NA